Return to Listing

3 result(s) for Gynecologic Cancers

PI Name Protocol # Title
Matthew Taylor IRB00011804 A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors
Lara Davis IRB00012039 Sarcoma Survivorship Registry
Tanja Pejovic STUDY00015737 (ONC-DPX-Survivac-06): A Phase 1b Study of an Immunotherapeutic Vaccine, DPX-Survivac with Low Dose Cyclophosphamide and Epacadostat (INCB024360) in Patients with Recurrent Ovarian Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080